GlycoErase™ AXIN2 Knockout HepG2 Cell Line (CAT#: GLJF-0825-JF619)

Description	GlycoErase™ AXIN2 knockout HepG2 cell line deletes AXIN2, a regulator of β-catenin stability in the Wnt signaling pathway. Dysregulation of AXIN2 has been associated with colorectal and other cancers. This knockout provides a system to dissect Wnt signaling dynamics, β-catenin regulation, and cancer biology, supporting oncology, developmental biology, and drug discovery targeting Wnt/β-catenin signaling.
Product Type	KO Cell Lines
Species	Human
Cell Morphology	Epithelial-like, adherent
Passage Ratio	1:4~1:6
Cell Line	HepG2
Primary Disease	Hepatoblastoma
Lineage	Liver
Lineage Subtype	Hepatoblastoma

Cell Viability	>90%
Sterility Test	The sterility test indicated an absence of microbial growth.
Identity Test	STR identification
Mycoplasma Test	Negative
Virus Test	Negative for HIV, HBV and HCV.
Genetic Stability Testing	We conduct cell genetic stability studies in full compliance with ICH guidelines. Our expertise enables us to design and execute a comprehensive testing program tailored to your specific needs and regulatory requirements.
Validation	PCR, Sanger Sequencing
Culture Medium	DMEM & FBS & Glutamine
Application	Functional assay
Size	1 M cells/vial*2
Product Format	Frozen
Shipping	Dry ice
Availability Status	Made to order
Handling Notes	Upon receipt, this product must be immediately transferred from dry ice to liquid nitrogen (-150°C to -190°C) and stored in a liquid nitrogen tank. Cell viability is critically dependent on proper handling. We cannot guarantee viability if these instructions are not strictly adhered to.
Product Disclaimer	This product is provided for research only, not suitable for human or animal use. Due to the inherent limitations of infectious agent testing, investigators must exercise extreme caution when handling cells provided by Creative Biolabs, treating all cells as potentially biohazardous.

Target	AXIN2
Full Name	Axin 2
Alternative Name	AXIL; ODCRCS
Location	17q24.1
Gene ID	8313
Summary	AXIN2, like its rodent counterparts, controls beta-catenin degradation in Wnt signaling by forming complexes with APC, beta-catenin, and GSK-3β. Altered AXIN2 function contributes to colorectal and other cancers.